These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

527 related items for PubMed ID: 26422096

  • 21. Efficacy and safety of lansoprazole in adolescents with symptomatic erosive and non-erosive gastroesophageal reflux disease.
    Fiedorek S, Tolia V, Gold BD, Huang B, Stolle J, Lee C, Gremse D.
    J Pediatr Gastroenterol Nutr; 2005 Mar; 40(3):319-27. PubMed ID: 15735486
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Clinical results from a randomized, double-blind, dose-ranging study of pantoprazole in children aged 1 through 5 years with symptomatic histologic or erosive esophagitis.
    Baker R, Tsou VM, Tung J, Baker SS, Li H, Wang W, Rath N, Maguire MK, Comer GM.
    Clin Pediatr (Phila); 2010 Sep; 49(9):852-65. PubMed ID: 20522615
    [Abstract] [Full Text] [Related]

  • 24. High rate of clinical and endoscopic relapse after healing of erosive peptic esophagitis in children and adolescents.
    Yamamoto E, Brito HS, Ogata SK, Machado RS, Kawakami E.
    J Pediatr Gastroenterol Nutr; 2014 Nov; 59(5):594-9. PubMed ID: 25023576
    [Abstract] [Full Text] [Related]

  • 25. The new proton pump inhibitor esomeprazole is effective as a maintenance therapy in GERD patients with healed erosive oesophagitis: a 6-month, randomized, double-blind, placebo-controlled study of efficacy and safety.
    Vakil NB, Shaker R, Johnson DA, Kovacs T, Baerg RD, Hwang C, D'Amico D, Hamelin B.
    Aliment Pharmacol Ther; 2001 Jul; 15(7):927-35. PubMed ID: 11421866
    [Abstract] [Full Text] [Related]

  • 26. Esomeprazole for the Treatment of GERD in Infants Ages 1-11 Months.
    Winter H, Gunasekaran T, Tolia V, Gottrand F, Barker PN, Illueca M.
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S9-15. PubMed ID: 26422097
    [Abstract] [Full Text] [Related]

  • 27. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable?
    Boccia G, Manguso F, Miele E, Buonavolontà R, Staiano A.
    Am J Gastroenterol; 2007 Jun; 102(6):1291-7. PubMed ID: 17319927
    [Abstract] [Full Text] [Related]

  • 28. Relationship between intragastric acid control and healing status in the treatment of moderate to severe erosive oesophagitis.
    Katz PO, Ginsberg GG, Hoyle PE, Sostek MB, Monyak JT, Silberg DG.
    Aliment Pharmacol Ther; 2007 Mar 01; 25(5):617-28. PubMed ID: 17305763
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Oral pantoprazole for erosive esophagitis: a placebo-controlled, randomized clinical trial. Pantoprazole US GERD Study Group.
    Richter JE, Bochenek W.
    Am J Gastroenterol; 2000 Nov 01; 95(11):3071-80. PubMed ID: 11095320
    [Abstract] [Full Text] [Related]

  • 32. Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial.
    Richter JE, Kahrilas PJ, Johanson J, Maton P, Breiter JR, Hwang C, Marino V, Hamelin B, Levine JG, Esomeprazole Study Investigators.
    Am J Gastroenterol; 2001 Mar 01; 96(3):656-65. PubMed ID: 11280530
    [Abstract] [Full Text] [Related]

  • 33. Efficacy of esomeprazole 40 mg vs. lansoprazole 30 mg for healing moderate to severe erosive oesophagitis.
    Fennerty MB, Johanson JF, Hwang C, Sostek M.
    Aliment Pharmacol Ther; 2005 Feb 15; 21(4):455-63. PubMed ID: 15709997
    [Abstract] [Full Text] [Related]

  • 34. Efficacy of lansoprazole in the treatment of gastroesophageal reflux disease in children.
    Tolia V, Ferry G, Gunasekaran T, Huang B, Keith R, Book L.
    J Pediatr Gastroenterol Nutr; 2002 Feb 15; 35 Suppl 4():S308-18. PubMed ID: 12607791
    [Abstract] [Full Text] [Related]

  • 35. The efficacy and safety of fexuprazan in treating erosive esophagitis: a phase III, randomized, double-blind, multicenter study.
    Zhuang Q, Liao A, He Q, Liu C, Zheng C, Li X, Liu Y, Wang B, Liu S, Zhang Y, Lin R, Chen H, Deng M, Tang Y, He C, Dai W, Tang H, Gong L, Li L, Xu B, Yang C, Zhou B, Su D, Guo Q, Li B, Zhou Y, Wang X, Fei S, Wu H, Wei S, Peng Z, Wang J, Li Y, Wang H, Deng T, Ding S, Li F, Chen M, Xiao Y.
    J Gastroenterol Hepatol; 2024 Apr 15; 39(4):658-666. PubMed ID: 38251791
    [Abstract] [Full Text] [Related]

  • 36. Esomeprazole for the Treatment of GERD in Infants Ages 1-11 Months.
    Winter H, Gunasekaran T, Tolia V, Gottrand F, Barker PN, Illueca M.
    J Pediatr Gastroenterol Nutr; 2015 Jul 15; 60 Suppl 1():S9-15. PubMed ID: 26121349
    [Abstract] [Full Text] [Related]

  • 37. Obesity does not affect treatment outcomes with proton pump inhibitors.
    Sharma P, Vakil N, Monyak JT, Silberg DG.
    J Clin Gastroenterol; 2013 Sep 15; 47(8):672-7. PubMed ID: 23442835
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Gastroesophageal reflux disease in intellectually disabled individuals: leads for diagnosis and the effect of omeprazole therapy.
    Bohmer CJ, Niezen-de Boer MC, Klinkenberg-Knol EC, Tuynman HA, Voskuil JH, Devillé WL, Meuwissen SG.
    Am J Gastroenterol; 1997 Sep 15; 92(9):1475-9. PubMed ID: 9317066
    [Abstract] [Full Text] [Related]

  • 40. Efficacy of pantoprazole 20 mg daily compared with esomeprazole 20 mg daily in the maintenance of healed gastroesophageal reflux disease: a randomized, double-blind comparative trial - the EMANCIPATE study.
    Goh KL, Benamouzig R, Sander P, Schwan T, EMANCIPATE.
    Eur J Gastroenterol Hepatol; 2007 Mar 15; 19(3):205-11. PubMed ID: 17301646
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.